Eczema has no single origin. It emerged from a combination of genetic mutations that weakened the skin’s outer barrier, environmental shifts that reduced early microbial exposure, and modern pollutants that didn’t exist for most of human history. The word itself comes from ancient Greek, meaning “to boil over,” a reference to the bubbling, inflamed skin that characterizes flare-ups. But the condition as we know it today, affecting up to 20% of children and 3% of adults worldwide, is largely a product of how human genes interact with modern living conditions.
The Genetic Roots
The strongest known genetic contributor to eczema is a mutation in the gene that produces filaggrin, a protein essential for building and maintaining the skin’s outermost protective layer. When filaggrin production is reduced or absent, the skin can’t hold moisture effectively and becomes more permeable to irritants, allergens, and bacteria. Filaggrin mutations are “loss of function” mutations, meaning the gene is essentially broken. People who carry two copies (one from each parent) have the highest risk of developing eczema.
These mutations aren’t evenly distributed across the globe. They’re most common in Northern European populations and become rarer closer to the equator. One hypothesis suggests this pattern exists because a leakier skin barrier actually allowed more ultraviolet light to penetrate the skin, boosting vitamin D production in regions with limited sunlight. In high-latitude environments where vitamin D deficiency could be fatal, this may have given carriers a survival edge, even at the cost of more irritable skin. The theory remains debated, but the geographic pattern is well documented.
Filaggrin isn’t the only player. Eczema skin also shows reduced levels of other structural proteins like loricrin, along with significant changes in ceramides, the waxy lipids that act as mortar between skin cells. When ceramide levels drop or their composition shifts, gaps form in the skin barrier. This is the most distinctive hallmark of eczema at a molecular level: a wall with missing bricks.
Why Eczema Became So Common
Genetics alone don’t explain why eczema rates have climbed so sharply. The prevalence of eczema in industrialized countries increased two to threefold over the last four decades of the 20th century. Genes don’t change that fast. Something about modern life is pulling the trigger.
The most prominent explanation is the hygiene hypothesis. Researchers noticed that children born later in birth order, those who shared bedrooms, attended daycare, or grew up in slightly more crowded homes, were less likely to develop eczema and other allergic conditions. The idea is straightforward: early exposure to a diverse range of microbes trains the immune system to distinguish between genuine threats and harmless substances like pollen or pet dander. Without that training, the immune system overreacts, producing the chronic inflammation that defines eczema.
The hypothesis fits the broad trends, but pinning down the exact exposures that matter has proven difficult. One large study found that the protective effects of crowding and room-sharing were real, but couldn’t trace them to any specific infections in early life. Antibiotic use in infancy, which wipes out beneficial gut bacteria, has been associated with higher eczema risk, but again the picture is incomplete. The hygiene hypothesis likely captures part of the truth, while leaving room for other modern factors.
Air Pollution and Urban Living
One of those factors is air quality. Traffic-related pollution, particularly fine particulate matter (PM2.5) and nitrogen dioxide, has been linked to both the onset and worsening of eczema. Exposure to PM2.5 is associated with roughly double the risk of developing eczema. A study of nearly 318,000 young people in Taiwan found significant links between eczema and traffic-related pollutants including carbon monoxide and nitrogen oxides, in both males and females.
Research in France, the United States, and other countries has reinforced this pattern. Children living near highways show higher rates of eczema even after accounting for other risk factors like family income and genetics. Sulfur dioxide and benzene have also been implicated. These pollutants damage the skin barrier directly and trigger inflammatory responses, essentially mimicking and amplifying the barrier defects that genetics already set in motion.
Bacteria on the Skin
Healthy skin hosts a diverse community of microorganisms that help regulate immune responses and keep harmful bacteria in check. In eczema, this community collapses. The diversity of skin bacteria drops, and one species dominates: Staphylococcus aureus. This bacterium lives harmlessly on the skin of 10 to 20% of healthy people, but it colonizes the affected skin of nearly 90% of eczema patients.
During flare-ups, S. aureus populations surge. The bacteria produce toxins that damage skin cells and trigger the release of inflammatory signals, which in turn activate mast cells (the same immune cells involved in allergic reactions). One toxin in particular directly stimulates the nerve endings responsible for itch, which helps explain the relentless scratching cycle that worsens eczema. The more a person scratches, the more the barrier breaks down, and the more bacteria flood in. Whether the bacterial overgrowth causes flare-ups or simply exploits an already weakened barrier is still being untangled, but the two clearly reinforce each other.
The Gut Connection
The relationship between gut health and eczema is an area of active investigation. The gut and the skin share an immune communication network sometimes called the gut-skin axis. Changes in gut bacteria composition have been linked to the development of eczema, though it’s still unclear whether an altered gut microbiome precedes the skin condition or develops alongside it. Stress hormones like cortisol can change gut permeability and shift microbial populations, which may partly explain why stress so reliably triggers eczema flares. The connection is real, but the direction of cause and effect remains murky.
How Doctors Recognize It
There is no blood test or lab marker that confirms eczema. Diagnosis relies on clinical criteria first developed by Hanifin and Rajka in 1980, which remain the standard. A diagnosis requires at least three of four major features: persistent itching, a rash in characteristic locations (the creases of elbows and knees in adults, the face and outer limbs in infants), a pattern of chronic or relapsing symptoms, and a personal or family history of allergic conditions like asthma or hay fever.
Beyond these, doctors look for a long list of supporting signs: unusually dry skin, darkened skin beneath the eyes, extra skin folds on the palms, plugged hair follicles on the upper arms, and a tendency toward skin infections. The breadth of these criteria reflects how variable eczema can be from person to person, which is partly why the condition took so long to be clearly defined in medical literature. The English physician Robert Willan published the first systematic classification of skin diseases in 1808, creating the framework that modern dermatology still builds on. Before that, eczema was lumped together with dozens of other rashes under vague, overlapping terms.
Putting It All Together
Eczema didn’t come from one place. It’s the product of ancient genetic vulnerabilities, possibly shaped by evolutionary pressures in northern climates, colliding with a modern world that offers cleaner indoor environments, dirtier outdoor air, and fewer of the microbial encounters that once calibrated the immune system during childhood. The skin barrier defect creates the opening. The immune system overreacts. Bacteria exploit the breach. And environmental triggers, from pollution to stress, keep the cycle spinning. Each of these layers helps explain not just why eczema exists, but why it has become so much more common in the span of a few generations.